The market didn't like it because 95% of the marke
Post# of 30028
Posted On: 08/03/2014 3:39:24 PM
Re: WCoastGuynCA #2998
The market didn't like it because 95% of the market doesn't understand what was being presented (me included).
As long as the scientists and pharma like it is all I care about.
I expect GC will expand on this in the blog tomorrow.
Read Chris' posts explaining univariate vs. multivariate.
I do believe that in this case, those that dumped are going to be very upset if they don't buy back in at these levels.
Don't listen to the guy who had his medical license taken away. He was a D.O. general practice physician. That's less school and credentials than an MD.
Patience, grasshopper. Just because the general market thinks the data was lousy, does not mean it's true. The point of this initial data was to prove that the old results could be duplicated in a western lab (univariate), now comes the tweaking (multivariate) since they know more about what they are looking for.
As long as the scientists and pharma like it is all I care about.
I expect GC will expand on this in the blog tomorrow.
Read Chris' posts explaining univariate vs. multivariate.
I do believe that in this case, those that dumped are going to be very upset if they don't buy back in at these levels.
Don't listen to the guy who had his medical license taken away. He was a D.O. general practice physician. That's less school and credentials than an MD.
Patience, grasshopper. Just because the general market thinks the data was lousy, does not mean it's true. The point of this initial data was to prove that the old results could be duplicated in a western lab (univariate), now comes the tweaking (multivariate) since they know more about what they are looking for.
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼